Clinical and regulatory intelligence for Behavioral Disorders with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Assets: 2

Relevant assets

memantine →

Semaglutide →

Relevant companies

No related entities indexed yet.

Recent signals(2)

ClinicalAugust 4, 2026

Semaglutide (Wegovy) Under Investigation for Trichotillomania Treatment

A clinical trial is underway to evaluate the safety and effectiveness of semaglutide for treating trichotillomania.

ClinicalAugust 3, 2026

Study Compares Behavioral Therapy vs. Memantine for Body Focused Repetitive Behaviors

A clinical trial is underway to evaluate the efficacy of behavioral treatment versus memantine in patients with trichotillomania and skin picking disorder.

Upcoming catalysts

No catalysts indexed for this entity yet.

Therapeutic areas

Behavioral Disorders →

Psychiatry →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.